Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where György Végh is active.

Publication


Featured researches published by György Végh.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 2004

How long should patients be followed after molar pregnancy? Analysis of serum hCG follow-up data.

József Bátorfi; György Végh; János Szepesi; Ivan Szigetvari; József Doszpod; Vilmos Fülöp

Abstract Objective : We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. Study design : One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis ( n =24; 16%). Results : Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. Conclusion : In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.


Obstetrical & Gynecological Survey | 2004

How Long Should Patients Be Followed After Molar Pregnancy? Analysis of Serum hCG Follow-Up Data

József Bátorfi; György Végh; János Szepesi; Ivan Szigetvari; József Doszpod; Vilmos Fülöp

OBJECTIVE We analyzed human chorionic gonadotropin (hCG) follow-up data of patients with molar pregnancy. Women often do not complete recommended post-disease screening. Our purpose was to determine if continuing follow up of uncomplicated molar cases beyond attaining undetectable hCG levels is necessary for detecting relapse of gestational trophoblastic disease. STUDY DESIGN One hundred fifty patients treated at Hungarian National Health Center were analyzed. Those who developed persistent disease before hCG had become undetectable were excluded from further analysis (n=24; 16%). RESULTS Among 126 uncomplicated cases, 72 patients (57%) completed follow up, and 54 (43%) discontinued their protocol before it had been completed. Of 120 patients who achieved at least one undetectable hCG level, none had any evidence of relapse. CONCLUSION In uncomplicated hydatidiform mole, our analysis indicates that once undetectable serum hCG levels are attained, relapse is unlikely. Although further monthly checks are advisable, the likelihood of recurrence appears very low.


Gynecologic Oncology | 2000

Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.

Z. Selcuk Tuncer; György Végh; Vilmos Fülöp; David R. Genest; Samuel C. Mok; Ross S. Berkowitz


Gynecologic Oncology | 1999

Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.

György Végh; Z. Selcuk Tuncer; Vilmos Fülöp; David R. Genest; Samuel C. Mok; Ross S. Berkowitz


Gynecologic Oncology | 1999

Differential Gene Expression Pattern between Normal Human Trophoblast and Choriocarcinoma Cell Lines: Downregulation of Heat Shock Protein-27 in Choriocarcinoma in Vitro and in Vivo

György Végh; Vilmos Fülöp; Yan Liu; Shu Wing Ng; Z. Selcuk Tuncer; David R. Genest; Piroska Páldi-Haris; János Földi; Samuel C. Mok; Ross S. Berkowitz


Journal of Reproductive Medicine | 2008

Primary pulmonary choriocarcinoma: A case report

György Végh; Ivan Szigetvari; Ibolya Soltész; Katalin Major; József Bátorfi; János Dancsó; László Zsirai; Vilmos Fülöp


Journal of Reproductive Medicine | 2010

30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary

Vilmos Fülöp; Ivan Szigetvari; János Szepesi; György Végh; József Bátorfi; Zoltan Nagymanyoki; Miklós Török; Ross S. Berkowitz


Journal of Reproductive Medicine | 2012

Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.

Vilmos Fülöp; Ivan Szigetvari; János Szepesi; György Végh; Margit Singh; Ross S. Berkowitz


Orvosi Hetilap | 2001

A c-erbB családba tartozó onkofehérjék normális lepényben és terhességi trophoblast-betegségekben (in vitro vizsgálatok).

Vilmos Fülöp; György Végh; József Doszpod


Journal of Reproductive Medicine | 2016

The role of surgery in the management of gestational trophoblastic neoplasia: The Hungarian experience

Vilmos Fülöp; Ivan Szigetvari; János Szepesi; György Végh; László Zsirai; Ross S. Berkowitz

Collaboration


Dive into the György Végh's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Samuel C. Mok

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

David R. Genest

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zoltan Nagymanyoki

Brigham and Women's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge